Related Experiment Video
Updated: Jan 6, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
The Three Pillars of Atrial Fibrillation Management
Mateusz Pajor1, Gregory Y H Lip2,3,4, Agnieszka Babińska1,4
11st Department of Cardiology and Angiology, Silesian Center for Heart Diseases, Zabrze, Poland.
Insights
Optimal atrial fibrillation (AF) management involves three pillars: stroke risk assessment, comorbidity treatment, and symptom control. A holistic, personalized approach to these interconnected factors improves patient outcomes and quality of life.
Area of Science:
- Cardiology
- Public Health
Background:
- Atrial fibrillation (AF) is the most common sustained arrhythmia, significantly impacting public health due to its links with stroke, heart failure, and dementia.
- Untreated AF increases stroke risk nearly fivefold, with AF accounting for one in five strokes.
Purpose of the Study:
- To outline the three essential pillars of optimal atrial fibrillation management.
- To emphasize the interconnectedness and need for a holistic, personalized treatment approach.
Main Methods:
- Review of current AF management strategies.
- Emphasis on the three core pillars: stroke risk assessment/prevention, comorbidity management, and symptom control (rhythm/rate control).
Main Results:
- Effective stroke prevention, primarily through oral anticoagulation, is the first pillar.
- Management of comorbidities and lifestyle factors is the second crucial pillar.
- Symptom management via rhythm or rate control constitutes the third pillar.
Conclusions:
- Optimal AF management requires a dynamic, personalized approach integrating all three pillars.
- Addressing stroke risk, comorbidities, and symptoms holistically improves prognosis and quality of life.
- Interconnectedness of pillars necessitates integrated care for better patient outcomes.
Abstract:
Atrial fibrillation (AF) is the most prevalent sustained arrhythmia, and given its associations with stroke, heart failure and dementia, AF confers a major impact on public health. Optimal AF management should be based on three pillars: assessment and treatment of stroke risk factors, treatment of comorbidities, and symptom management through rhythm/rate control. In untreated AF, depending on other risk factors, the risk of stroke increases almost fivefold, and one in five strokes is related to AF. Therefore, effective assessment and prevention of stroke are the first pillar of AF management. The basis of stroke prevention is oral anticoagulation, which includes vitamin K antagonists and direct oral anticoagulants. Comorbidities and lifestyle factors exert a substantial influence on the progression risk, course, symptom severity, and prognosis in patients with AF. Hence, the appropriate management of these factors represents a crucial aspect, being the second pillar of AF treatment. The last pillar of AF management is symptom management through rhythm or rate control. Rhythm control in AF encompasses sinus rhythm restoration (antiarrhythmic drugs, cardioversion, and ablation techniques). Conversely, rate control aims to maintain AF while ensuring a well-regulated ventricular rate. Each of these pillars needs regular reassessment and dynamic shared decision-making with patients. The aim of AF treatment is to reduce mortality and improve prognosis and quality of life, which is influenced by each of the three pillars. In addition, it is important to emphasise that each pillar is linked to the others. For example, comorbidities increase the risk of stroke, and inadequate rhythm/rate control can accelerate the development of heart failure. Therefore, treatment of AF must not be punctual, but holistic and personalised, as outlined in this review.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Mitral Stenosis III: Medical Management
Venous Thrombosis III: Interprofessional Care
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mitral Regurgitation III: Medical Management
Atherosclerosis III: Management

